Codeine crackdown could cost $1.27 billion over four years… and more
Upscheduling codeine-containing OTCs could cost upwards of $1.27 billion in MBS outlay alone over the next four years, a new report has found. The Pharmacy Guild engaged Cadence Economics to …
Momentum building for switch environment, S3 advertising policy: ASMI
Momentum is building for reform of the switch environment and Schedule 3 advertising policy, said presenters and participants at ASMI’s annual conference yesterday. ASMI Chief Executive Officer, Deon Schoombie, said: …
PSA calls for pharmacists to be included in MBS items
The PSA has called for the Medical Benefits Scheme to be expanded to allow pharmacists to help improve consumer health outcomes and quality use of medicines. In the PSA submission …
Lagging on climate change action affects health: PHAA
The Public Health Association of Australia has welcomed a report from the World Federation of Public Health Associations revealing the many countries lagging behind in policies that protect their populations …
Small change could slash childhood obesity rates
Australia’s rates of childhood overweight and obesity could be turned around with changes equivalent to cutting one small chocolate bar and getting in 15 minutes of exercise, according to research …
PSA launches PSA16: leading pharmacy innovation
The Pharmaceutical Society of Australia’s national conference, PSA16, will be held at Four Points by Sheraton, Darling Harbour in July 2016, the PSA says. The venue was announced at a …
ASMI demonstrates mock Schedule 3 ads
Today at its annual conference in Sydney the Australian Self Medication Industry shared a ‘sample mock ad’, which demonstrated the proposed consumer communication model it has been advocating for Schedule …
Biggest syphilis outbreak in 30 years prompts screening call
Queensland’s peak Aboriginal and Islander health body has called for changes to health screening and increased investment into sexual health in the face of Australia’s biggest reported syphilis outbreak in …
New Board of Directors for ASMI
At its Annual General Meeting today, ASMI announced its new Board of Directors. ASMI Chief Executive Officer, Deon Schoombie, congratulated and welcomed the ASMI Board Members. “ASMI’s new Board includes …
Generic Medicines Working Group identifies priorities
Four policy priorities that will safeguard affordable access to medicines in Australia while ensuring the generic and biosimilar medicines industry remains viable have been agreed to by the Federal Government. …
Why upscheduling codeine combination products is a really bad idea
Professor Peter Carroll, Dr Rebekah Moles, Dr Slade Matthews, Stuart Nankivell and Nick Logan (Members of the NSW Poisons Advisory Committee) on why they think upscheduling combination codeine products is …
Situation stable: 2015 UTS Pharmacy Barometer
More pharmacists are confident in the future viability of community-based pharmacy than they were 12 months ago, however the majority remain “neutral” about the future rather than optimistic, according to the results of this year’s UTS Community Pharmacy Barometer.